ARA-290 (cibinetide): a research overview

ARA-290, also called cibinetide, is a short peptide studied in tissue-protective and innate-repair research. This overview describes its structure and handling for an in-vitro research audience, with no therapeutic or dosing claims.

What it is

ARA-290 is an 11-amino-acid peptide derived from the Helix B region of erythropoietin (EPO). It is studied because that region is associated with tissue-protective signalling that is distinct from EPO's well-known effect on red-blood-cell production.

Why it is studied

ARA-290 features in preclinical and in-vitro literature on innate repair and tissue protection. Findings belong to those studies; nothing here is a statement about human effects.

Handling notes

• Supplied lyophilised; reconstitute gently without shaking.
• Keep the dry solid sealed, cold and dark.
• Refrigerate after reconstitution and aliquot for repeated use.

For in-vitro research use only. Not for human or veterinary use.